Medica Group PLC Stock: price and insider trades · United Kingdom

GB00BYV24996GB·

No insider purchase over the last 90 days. The latest, by Sarah Lavis, was filed 10 Nov 2022.

Medica Group PLC: what insiders have been doing

Medica Group PLC is a listed company. Its directors and officers file their transactions with RNS (LSE). The past year has been quiet: not a single insider filing for Medica Group PLC. The previous disclosure was published on 5 July 2023.

Looking back to 2018, when coverage begins, insiders filed 14 purchases and 4 sales.

Source: insider filings from RNS (LSE). Past trades are no guide to future returns.

Insider Decl.

Thresholds

n/a

Buy Volume

€567,374

14 ops. · all time

Sell Volume

€1M

4 ops. · all time

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Financial data

· cache

Last declaration on 5 July 2023

Declarations31 total

◆
1. Stuart Quin 2. Richard Jones 3. Kevin Terrins 4. Sarah Burns 5. Marc O'Brien 6. Caroline Byrne 7. Rob Lavis 8. Fiona Carr 9. Kim Scanlan
1. Chief Executive Officer 2. Chief Financial Officer 3. Group Director of Corporate Development 4. Managing Director, UK 5. Chief Information Officer 6. Managing Director, Ireland 7. Group Medical Director 8. Group Head of Human Resources 9. Managing Director, USExecutives4 Jul 2023
0RNS
0Outside a trading venueRNS:4826270-0
◆
1. Stuart Quin 2. Richard Jones 3. Kevin Terrins 4. Sarah Burns 5. Marc O'Brien 6. Caroline Byrne 7. Rob Lavis 8. Fiona Carr 9. Kim Scanlan
1. Chief Executive Officer 2. Chief Financial Officer 3. Group Director of Corporate Development 4. Managing Director, UK 5. Chief Information Officer 6. Managing Director, Ireland 7. Group Medical Director 8. Group Head of Human Resources 9. Managing Director, USExecutives4 Jul 2023
0RNS
0Outside a trading venueRNS:4826270-1
◆
1. Stuart Quin 2. Richard Jones 3. Kevin Terrins 4. Sarah Burns 5. Marc O'Brien 6. Caroline Byrne 7. Rob Lavis 8. Fiona Carr 9. Kim Scanlan
1. Chief Executive Officer 2. Chief Financial Officer 3. Group Director of Corporate Development 4. Managing Director, UK 5. Chief Information Officer 6. Managing Director, Ireland 7. Group Medical Director 8. Group Head of Human Resources 9. Managing Director, USExecutives4 Jul 2023
0RNS
0Outside a trading venueRNS:4826270-2
◆
1. Stuart Quin 2. Richard Jones 3. Kevin Terrins 4. Sarah Burns 5. Marc O'Brien 6. Caroline Byrne 7. Rob Lavis 8. Fiona Carr 9. Kim Scanlan
1. Chief Executive Officer 2. Chief Financial Officer 3. Group Director of Corporate Development 4. Managing Director, UK 5. Chief Information Officer 6. Managing Director, Ireland 7. Group Medical Director 8. Group Head of Human Resources 9. Managing Director, USExecutives4 Jul 2023
0RNS
0Outside a trading venueRNS:4826270-3
◆
1. Stuart Quin 2. Richard Jones 3. Kevin Terrins 4. Sarah Burns 5. Marc O'Brien 6. Caroline Byrne 7. Rob Lavis 8. Fiona Carr 9. Kim Scanlan
1. Chief Executive Officer 2. Chief Financial Officer 3. Group Director of Corporate Development 4. Managing Director, UK 5. Chief Information Officer 6. Managing Director, Ireland 7. Group Medical Director 8. Group Head of Human Resources 9. Managing Director, USExecutives4 Jul 2023
0RNS
0Outside a trading venueRNS:4826270-4
▲
Sarah Lavis
PCA of Dr Robert Lavis, Group Medical DirectorExecutives8 Nov 2022
499 GBP0FCA-NSM
368 shares@ £1.3554XLONISIN GB00BYV24996FCA-NSM:4575633
Canonical exit: 6 Feb 2023 (T+90)
▲
Mallika Kaviratne
PCA of Dr Stuart Quin, Chief Executive OfficerExecutives21 Oct 2022
74,875 GBP15FCA-NSM
59,900 shares@ £1.25100.0% of flowXLONISIN GB00BYV24996FCA-NSM:4552984
Canonical exit: 19 Jan 2023 (T+90)
●
Stuart Quin
Chief Executive OfficerExecutives1 Nov 2021
0FCA-NSM
26,546 sharesOutside a trading venueISIN GB00BYV24996FCA-NSM:4163932
▲
Kevin Terrins
Business Development DirectorExecutives18 Jun 2021
24,873 GBP0FCA-NSM
14,295 shares@ £1.74XLONISIN GB00BYV24996FCA-NSM:4014823
Canonical exit: 16 Sept 2021 (T+90)
▲
Stuart Quin
Chief Executive OfficerExecutives10 Jun 2021
29,700 GBP0FCA-NSM
19,505 shares@ £1.5227XLONISIN GB00BYV24996FCA-NSM:4007298
Canonical exit: 8 Sept 2021 (T+90)
◆
1. Richard Jones 2. Rob Lavis 3. Sarah Burns
1. Chief Financial Officer 2. Medical Director 3. Chief Operating OfficerExecutives4 Jun 2021
43,197 GBP0FCA-NSM
29,587 shares@ £1.46Outside of trading venueISIN GB00BYV24996FCA-NSM:3999518
●
Kevin Terrins
Director of Business DevelopmentExecutives3 Dec 2020
0FCA-NSM
1,200,000 sharesOutside a trading venueISIN GB00BYV24996FCA-NSM:3804654
●
Stephen Davies
Medical Director and Responsible Officer/PDMRExecutives30 Nov 2020
0FCA-NSM
521,032 sharesOutside a trading venueISIN GB00BYV24996FCA-NSM:3800967-0
▼
Stephen Davies
Medical Director and Responsible Officer/PDMRExecutives30 Nov 2020
1M GBP31FCA-NSM
1,031,924 shares@ £120.00100.0% of flowXLONISIN GB00BYV24996FCA-NSM:3800967-1
▼
Mary Davies
PCA/ Dr Stephen Davies (Medical Director and Responsible Officer)Executives30 Nov 2020
47,368 GBP27FCA-NSM
47,368 shares@ £120.00100.0% of flowXLONISIN GB00BYV24996FCA-NSM:3800967-2
●
Stuart Quin
Chief Executive Officer/PDMRExecutives1 Dec 2020
60,000 GBP30FCA-NSM
60,000 shares100.0% of flowOutside a trading venueISIN GB00BYV24996FCA-NSM:3800967-3
▲
Stuart Quin
Chief Executive OfficerExecutives4 Nov 2020
29,701 GBP0FCA-NSM
27,680 shares@ £1.073XLONISIN GB00BYV24996FCA-NSM:3770235-0
Canonical exit: 2 Feb 2021 (T+90)
▲
Richard Jones
Chief Financial OfficerExecutives4 Nov 2020
19,995 GBP0FCA-NSM
18,260 shares@ £1.095XLONISIN GB00BYV24996FCA-NSM:3770235-1
Canonical exit: 2 Feb 2021 (T+90)
▲
Max Neal Easton
Non Executive DirectorExecutives11 Jun 2020
1,978 GBP15FCA-NSM
1,512 shares@ £1.308100.0% of flowLondon Stock Exchange, Main Market (XLON)ISIN GB00BYV24996FCA-NSM:3623497
Canonical exit: 9 Sept 2020 (T+90)
◆
Kevin Terrins
Business Development DirectorExecutives14 May 2020
18,000 GBP0FCA-NSM
18,000 shares@ £1.00Outside of trading venueFCA-NSM:3595690
◆
Stuart Quin
Chief Executive OfficerExecutives14 May 2020
18,000 GBP0FCA-NSM
18,000 shares@ £1.00Outside of trading venueFCA-NSM:3595685
◆
Marc O'Brien
Chief Technical OfficerExecutives14 May 2020
18,000 GBP0FCA-NSM
18,000 shares@ £1.00Outside of trading venueFCA-NSM:3595758
▲
1. Dr Stephen Davies
1. Medical DirectorExecutives15 Apr 2020
60,000 GBP0FCA-NSM
51,282 shares@ £1.17Outside a trading venueFCA-NSM:3564671
Canonical exit: 14 Jul 2020 (T+90)
▲
1. Dr Stephen Davies
1. Medical DirectorExecutives9 Apr 2020
60,000 GBP37FCA-NSM
58,252 shares@ £1.03100.0% of flowOutside a trading venueFCA-NSM:3559607
Canonical exit: 8 Jul 2020 (T+90)
▲
1. Marc O'Brien
1. Chief Technical OfficerExecutives9 Apr 2020
9,938 GBP37FCA-NSM
9,556 shares@ £1.04100.0% of flowOutside a trading venueFCA-NSM:3559604
Canonical exit: 8 Jul 2020 (T+90)

25 of 31 declarations

About Medica Group PLC

Medica Group PLC is a UK-based company that specializes in providing medical diagnostic services. It primarily operates in the field of medical imaging and reporting for hospitals and clinics.

Medica Group PLC Stock: price and insider trades · United Kingdom

Medica Group PLC: what insiders have been doing

Financial data

About Medica Group PLC

Similar companies